Hyeonseok Jeong

Hyeonseok Jeong

Auto-generated profile, based on publicly available information

Hyeonseok Jeong

Department of Radiology Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea Seoul South Korea

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Ultrasonography
Verified
Journal Article
Open access
PDF file
HJHyeonseok Jeong
Hyeonseok Jeong
JIJooyeon Jamie Im
Jooyeon Jamie Im
JPJong-Sik Park
Jong-Sik Park
SNSeunghee Na
Seunghee Na
WLWonhye Lee
Wonhye Lee
Yong An ChungYong An Chung
Yong An Chung
Purpose: Increasing attention has been paid to low-intensity transcranial focused ultrasound (tFUS) for its potential therapeutic effects in Alzheimer's disease (AD). While preclinical studies have shown promising therapeutic effects of low-intensity tFUS in AD models, its efficacy and safety remain unclear in humans. In this pilot study, we investigated the effects of low-intensity tFUS on blood-brain barrier opening, the regional cerebral metabolic rate of glucose (rCMRglu), and cognition in patients with AD.Methods: After receiving institutional review board approval, four patients with AD received tFUS to the hippocampus immediately after an intravenous injection of a microbubble ultrasound contrast agent. Sonication was delivered at low-intensity, at a pressure level below the threshold for blood-brain barrier opening. Patients underwent brain magnetic resonance imaging, 18F-fluoro-2-deoxyglucose positron emission tomography, and neuropsychological assessments before and after the tFUS procedure. A whole-brain voxel-wise paired t test was conducted to compare rCMRglu before and after tFUS.Results: The sonication, as anticipated, did not show evidence of active blood-brain barrier opening on T1 dynamic contrast-enhanced magnetic resonance imaging. rCMRglu in the superior frontal gyrus (P<0.001), middle cingulate gyrus (P<0.001), and fusiform gyrus increased after tFUS (P=0.001). Patients demonstrated mild improvement in measures of memory, executive, and global cognitive function following tFUS. No adverse events were reported.Conclusion: These results suggest that hippocampal sonication with low-intensity tFUS may have beneficial effects on cerebral glucose metabolism and cognitive function in patients with AD. Further larger studies are needed to confirm the therapeutic efficacy of tFUS in AD.

Verified
Journal Article
Open access
PDF file
HJHyeonseok Jeong
Hyeonseok Jeong
ISIn-Uk Song
In-Uk Song
Yong An ChungYong An Chung
Yong An Chung
JPJong-Sik Park
Jong-Sik Park
SNSeunghee Na
Seunghee Na
SYSeung-Schik Yoo
Seung-Schik Yoo
Preclinical studies have suggested that low-intensity transcranial focused ultrasound (tFUS) may have therapeutic potential for Alzheimer’s disease (AD) by opening the blood–brain barrier (BBB), reducing amyloid pathology, and improving cognition. This study investigated the effects of tFUS on BBB opening, regional cerebral metabolic rate of glucose (rCMRglu), and cognitive function in AD patients. Eight patients with AD received image-guided tFUS to the right hippocampus immediately after intravenous injection of microbubble ultrasound contrast agents. Patients completed magnetic resonance imaging (MRI), 18F-fluoro-2-deoxyglucose positron emission tomography (PET), and cognitive assessments before and after the sonication. No evidence of transient BBB opening was found on T1 dynamic contrast-enhanced MRI. However, immediate recall (p = 0.03) and recognition memory (p = 0.02) were significantly improved on the verbal learning test. PET image analysis demonstrated increased rCMRglu in the right hippocampus (p = 0.001). In addition, increases of hippocampal rCMRglu were correlated with improvement in recognition memory (Spearman’s ρ = 0.77, p = 0.02). No adverse event was observed. Our results suggest that tFUS to the hippocampus of AD patients may improve rCMRglu of the target area and memory in the short term, even without BBB opening. Further larger sham-controlled trials with loger follow-up are warranted to evaluate the efficacy and safety of tFUS in patients with AD.

12 November 2018 in Journal of Behavioral Addictions
Verified
Journal Article
Open access
SLSang Hoon Lee
Sang Hoon Lee
JIJooyeon Jamie Im
Jooyeon Jamie Im
JOJin Kyoung Oh
Jin Kyoung Oh
ECEun Kyoung Choi
Eun Kyoung Choi
SYSujung Yoon
Sujung Yoon
Yong An ChungYong An Chung
Yong An Chung
Aim: Excessive use of online games can have negative influences on mental health and daily functioning. Although the effects of transcranial direct current stimulation (tDCS) have been investigated for the treatment of addiction, it has not been evaluated for excessive online game use. This study aimed to investigate the feasibility and tolerability of tDCS over the dorsolateral prefrontal cortex (DLPFC) in online gamers. Methods: A total of 15 online gamers received 12 active tDCS sessions over the DLPFC (anodal left/cathodal right, 2 mA for 30 min, 3 times per week for 4 weeks). Before and after tDCS sessions, all participants underwent 18F-fluoro-2-deoxyglucose positron emission tomography scans and completed the Internet Addiction Test (IAT), Brief Self Control Scale (BSCS), and Beck Depression Inventory-II (BDI-II). Results: After tDCS sessions, weekly hours spent on games (p = .02) and scores of IAT (p < .001) and BDI-II (p = .01) were decreased, whereas BSCS score was increased (p = .01). Increases in self-control were associated with decreases in both addiction severity (p = .002) and time spent on games (p = .02). Moreover, abnormal right-greater-than-left asymmetry of regional cerebral glucose metabolism in the DLPFC was partially alleviated (p = .04). Conclusions: Our preliminary results suggest that tDCS may be useful for reducing online game use by improving interhemispheric balance of glucose metabolism in the DLPFC and enhancing self-control. Larger sham-controlled studies with longer follow-up period are warranted to validate the efficacy of tDCS in gamers.

1 October 2013 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
SYSujung Yoon
Sujung Yoon
CJChansoo S. Jun
Chansoo S. Jun
HJHyeonseok S. Jeong
Hyeonseok S. Jeong
Sunho LeeSunho Lee
Sunho Lee
SLSoo Mee Lim
Soo Mee Lim
ILIn Kyoon Lyoo
In Kyoon Lyoo

23 September 2020 in Metabolites
Verified
Journal Article
Open access
PDF file
SNSeunghee Na
Seunghee Na
HJHyeonseok Jeong
Hyeonseok Jeong
JPJong-Sik Park
Jong-Sik Park
Yong An ChungYong An Chung
Yong An Chung
ISIn-Uk Song
In-Uk Song
The neuropathology of Parkinson’s disease dementia (PDD) is heterogenous, and the impacts of each pathophysiology and their synergistic effects are not fully understood. The aim of this study was to evaluate the frequency and impacts of co-existence with Alzheimer’s disease in patients with PDD by using 18F-florbetaben PET imaging. A total of 23 patients with PDD participated in the study. All participants underwent 18F-florbetaben PET and completed a standardized neuropsychological battery and assessment of motor symptoms. The results of cognitive tests, neuropsychiatric symptoms, and motor symptoms were analyzed between the positive and negative 18F-florbetaben PET groups. Four patients (17.4%) showed significant amyloid burden. Patients with amyloid-beta showed poorer performance in executive function and more severe neuropsychiatric symptoms than those without amyloid-beta. Motor symptoms assessed by UPDRS part III and the modified H&Y Scale were not different between the two groups. The amyloid PET scan of a patient with PDD can effectively reflect a co-existing Alzheimer’s disease pathology. Amyloid PET scans might be able to help physicians of PDD patients showing rapid progression or severe cognitive/behavioral features.

1 January 2018 in Dementia and Neurocognitive Disorders
Verified
Journal Article
Open access
HJHyeonseok Jeong
Hyeonseok Jeong
IKIlhyang Kang
Ilhyang Kang
JIJooyeon J. Im
Jooyeon J. Im
JPJong-Sik Park
Jong-Sik Park
SNSeung-Hee Na
Seung-Hee Na
ISIn-Uk Song
In-Uk Song
Jeong H, et al. Dement Neurocognitive Disord. 2018 Jun;17(2):50-56. https://doi.org/10.12779/dnd.2018.17.2.50